Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

Total article views   HTML views PDF downloads Totals
12,548 Dovepress* 11,385+ 2,112 13,497
PubMed Central* 1,163 476 1,639
Totals 12,548 2,588 15,136
*Since 23 August 2012
+Since July 2016

View citations on PubMed Central and Google Scholar